Role of apoptosis of renal tubular cells in acute renal failure: Therapeutic implications

被引:79
作者
Rana, A
Sathyanarayana, P
Lieberthal, W
机构
[1] Cardiovasc Res Inst, Temple, TX 76504 USA
[2] Massachusetts Gen Hosp, Diabet Res Unit, Boston, MA 02114 USA
[3] Harvard Univ, Sch Med, Boston, MA USA
[4] Boston Univ, Sch Med, Evans Dept Clin Res, Dept Nephrol, Boston, MA 02118 USA
关键词
acute renal failure; apoptosis; Bcl-2; MAPK; necrosis;
D O I
10.1023/A:1009680229931
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Acute renal failure (ARF) can be defined as a sudden loss of renal function and is a common and serious clinical problem. There are many causes of ARF but the most common cause results from injury to the renal tubular epi-thelial cells (RTECs). RTECs can be injured by schemia or by cytotoxic agents and, once injured, can die by necrosis or apotosis. In general, necrosis occurs in response to any severe injury, which leads to the biochemical collapse of the cell. Milder forms of the same types of injury cause apoptosis. At the cellular level there are fundamental differences between necrosis and apoptosis. Necrosis results from the additive effect of a number of independent biochemical events that are activated by severe depletion of cell energy stores. By contrast, apoptosis occurs via a coordinated, predictable and pre-determined pathway. These biochemical differences between apoptosis and necrosis have important therapeutic implications. Once a cell has been severely injured, necrosis is difficult to prevent. By contrast, the apoptotic pathway can potentially be modulated to maintain cell viability. The components of the apoptotic pathway that are potentially amenable to therapeutic modulation are discussed in detail in this review.
引用
收藏
页码:83 / 102
页数:20
相关论文
共 171 条
[1]  
Abassi ZA, 1998, SEMIN NEPHROL, V18, P558
[2]   The Bcl-2 protein family: Arbiters of cell survival [J].
Adams, JM ;
Cory, S .
SCIENCE, 1998, 281 (5381) :1322-1326
[3]   Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase B alpha [J].
Alessi, DR ;
James, SR ;
Downes, CP ;
Holmes, AB ;
Gaffney, PRJ ;
Reese, CB ;
Cohen, P .
CURRENT BIOLOGY, 1997, 7 (04) :261-269
[4]   3 Phosphoinositide-dependent protein kinase 1 (PDK1) phosphorylates and activates the p70 S6 kinase in vivo and in vitro [J].
Alessi, DR ;
Kozlowski, MT ;
Weng, QP ;
Morrice, N ;
Avruch, J .
CURRENT BIOLOGY, 1998, 8 (02) :69-81
[5]   Inhibition of Bax channel-forming activity by Bcl-2 [J].
Antonsson, B ;
Conti, F ;
Ciavatta, A ;
Montessuit, S ;
Lewis, S ;
Martinou, I ;
Bernasconi, L ;
Bernard, A ;
Mermod, JJ ;
Mazzei, G ;
Maundrell, K ;
Gambale, F ;
Sadoul, R ;
Martinou, JC .
SCIENCE, 1997, 277 (5324) :370-372
[6]   Death receptors: Signaling and modulation [J].
Ashkenazi, A ;
Dixit, VM .
SCIENCE, 1998, 281 (5381) :1305-1308
[7]   Epidermal growth factor (EGF)-induced generation of hydrogen peroxide - Role in EGF receptor-mediated tyrosine phosphorylation [J].
Bae, YS ;
Kang, SW ;
Seo, MS ;
Baines, IC ;
Tekle, E ;
Chock, PB ;
Rhee, SG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (01) :217-221
[8]   LACTATE PRODUCTION IN ISOLATED SEGMENTS OF THE RAT NEPHRON [J].
BAGNASCO, S ;
GOOD, D ;
BALABAN, R ;
BURG, M .
AMERICAN JOURNAL OF PHYSIOLOGY, 1985, 248 (04) :F522-F526
[9]  
BAGRODIA S, 1995, J BIOL CHEM, V270, P27995
[10]  
Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424